drugset / Trial / NCT03061136

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

NCT03061136 ↗

RandomizedCrossoverTriple-blindTreatment

Summary

Cognitive deficits are some of the most prominent and disabling symptoms of schizophrenia. Evidence suggests that schizophrenia involves alterations to the functioning of a neural system under the control of a brain chemical called GABA. The present project will compare the effects of low-dose clonazepam (at a sub-sedating dose) to placebo, for effects on GABA- modulated brain activity measured by EEG, and associated cognitive processes in people who have schizophrenia.

Timeline

Start
2016-10
Primary completion
2017-10
Completion
2017-10

Outcome

Outcome not reported

Stopped: “Delays in equipment procurement prevented the start of the study in time”

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonazepam Small molecule 0.1 mg Oral
Subject Clonazepam Small molecule 0.2 mg Oral
Subject Clonazepam Small molecule 0.3 mg Oral